Search Page

1

Cite

Share

Repurposing Peroxisome Proliferator-Activated Receptor Agonists in Neurological and Psychiatric Disorders.

Sagheddu C, Melis M, Muntoni AL, Pistis M. Sagheddu C, et al. Among authors: pistis m. Pharmaceuticals (Basel). 2021 Oct 8;14(10):1025. doi: 10.3390/ph14101025. Pharmaceuticals (Basel). 2021. PMID: 34681249 Free PMC article. Review.

Cite

Share

2

Cite

Share

The Role of Nuclear Hormone Receptors in Cannabinoid Function.

Pistis M, O'Sullivan SE. Pistis M, et al. Adv Pharmacol. 2017;80:291-328. doi: 10.1016/bs.apha.2017.03.008. Epub 2017 May 25. Adv Pharmacol. 2017. PMID: 28826538 Review.

Cite

Share

3

Cite

Share

Neurobiological mechanisms of cannabinoid addiction.

Fattore L, Fadda P, Spano MS, Pistis M, Fratta W. Fattore L, et al. Among authors: pistis m. Mol Cell Endocrinol. 2008 Apr 16;286(1-2 Suppl 1):S97-S107. doi: 10.1016/j.mce.2008.02.006. Epub 2008 Feb 16. Mol Cell Endocrinol. 2008. PMID: 18372102 Review.

Cite

Share

4

Cite

Share

Conjugated Linoleic Acid and Brain Metabolism: A Possible Anti-Neuroinflammatory Role Mediated by PPARα Activation.

Murru E, Carta G, Manca C, Sogos V, Pistis M, Melis M, Banni S. Murru E, et al. Among authors: pistis m. Front Pharmacol. 2021 Jan 8;11:587140. doi: 10.3389/fphar.2020.587140. eCollection 2020. Front Pharmacol. 2021. PMID: 33505308 Free PMC article. Review.

Cite

Share

5

Cite

Share

Anti-IL5 Drugs in COVID-19 Patients: Role of Eosinophils in SARS-CoV-2-Induced Immunopathology.

Pala D, Pistis M. Pala D, et al. Among authors: pistis m. Front Pharmacol. 2021 Mar 9;12:622554. doi: 10.3389/fphar.2021.622554. eCollection 2021. Front Pharmacol. 2021. PMID: 33767626 Free PMC article.

Cite

Share

6

Cite

Share

Reinstatement of synaptic plasticity in the aging brain through specific dopamine transporter inhibition.

Lubec J, Kalaba P, Hussein AM, Feyissa DD, Kotob MH, Mahmmoud RR, Wieder O, Garon A, Sagheddu C, Ilic M, Dragačević V, Cybulska-Klosowicz A, Zehl M, Wackerlig J, Sartori SB, Ebner K, Kouhnavardi S, Roller A, Gajic N, Pistis M, Singewald N, Leban JJ, Korz V, Malikovic J, Plasenzotti R, Sitte HH, Monje FJ, Langer T, Urban E, Pifl C, Lubec G. Lubec J, et al. Among authors: pistis m. Mol Psychiatry. 2021 Dec;26(12):7076-7090. doi: 10.1038/s41380-021-01214-x. Mol Psychiatry. 2021. PMID: 34244620

Cite

Share

7

Cite

Share

Endocannabinoid-Like Lipid Neuromodulators in the Regulation of Dopamine Signaling: Relevance for Drug Addiction.

Sagheddu C, Torres LH, Marcourakis T, Pistis M. Sagheddu C, et al. Among authors: pistis m. Front Synaptic Neurosci. 2020 Dec 23;12:588660. doi: 10.3389/fnsyn.2020.588660. eCollection 2020. Front Synaptic Neurosci. 2020. PMID: 33424577 Free PMC article. Review.

Cite

Share

8

Cite

Share

N-Acylethanolamine Acid Amidase Inhibition Potentiates Morphine Analgesia and Delays the Development of Tolerance.

Congiu M, Micheli L, Santoni M, Sagheddu C, Muntoni AL, Makriyannis A, Malamas MS, Ghelardini C, Di Cesare Mannelli L, Pistis M. Congiu M, et al. Among authors: pistis m. Neurotherapeutics. 2021 Oct;18(4):2722-2736. doi: 10.1007/s13311-021-01116-4. Epub 2021 Sep 22. Neurotherapeutics. 2021. PMID: 34553321 Free PMC article.

Cite

Share

9

Cite

Share

Hub and switches: endocannabinoid signalling in midbrain dopamine neurons.

Melis M, Pistis M. Melis M, et al. Among authors: pistis m. Philos Trans R Soc Lond B Biol Sci. 2012 Dec 5;367(1607):3276-85. doi: 10.1098/rstb.2011.0383. Philos Trans R Soc Lond B Biol Sci. 2012. PMID: 23108546 Free PMC article. Review.

Cite

Share

10

Cite

Share

The endocannabinoid system and nondrug rewarding behaviours.

Fattore L, Melis M, Fadda P, Pistis M, Fratta W. Fattore L, et al. Among authors: pistis m. Exp Neurol. 2010 Jul;224(1):23-36. doi: 10.1016/j.expneurol.2010.03.020. Epub 2010 Mar 29. Exp Neurol. 2010. PMID: 20353776 Review.

Cite

Share